BioSpace News Archive

Since the outset of the COVID-19 pandemic, the Government of Canada has used the latest science and evidence to inform our response.

The Alzheimer’s Drug Discovery Foundation (ADDF) announces two new members to its Board of Governors : Sharon T. Sager , CIMA, Managing Director and Private Wealth Advisor at UBS Private Wealth Management and Beatriz Illescas Putzeys-Claugus , Founder and Director of The Foundation for a Better World. They will help guide the ADDF in

--Study highlights wide range of pediatric cancers in which NTRK fusions are more likely to occur, which could help prioritize testing for targeted treatment with FDA-approved TRK inhibitors--

Toronto, Ontario--(Newsfile Corp. - January 15, 2021) - Therma Bright Inc. (TSXV: THRM) (“Therma” or the “Company”), a progressive medical device technology company, is pleased to announce the appointment of Ian Levine to the advisory board to assist with future scaling for the manufacture of CoviSafe™.

Toronto, Ontario--(Newsfile Corp. - January 15, 2021) - Awakn Life Sciences announced today the selection of contract research organization (‘CRO’), PRA Health Sciences (NASDAQ: PRAH), to conduct a Phase IIb trial studying the effectiveness of MDMA-Assisted Psychotherapy as a treatment for patients with Non-Physically Dependent (‘Harmful Use’) Alcohol Use Disorder (“AUD”).

Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced today that it has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the Sputnik V vaccine in India. The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India. Earlie

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that, in compliance with the Florida Business Corporations Act, and

The U.S. District Court for the Eastern District of Washington entered a consent decree between the U.S. Food and Drug Administration and Valley Processing, Inc. of Sunnyside, Washington, along with the company’s owner and president, Mary Ann Bliesner, to stop distributing adulterated juice products until the company complies with the Federal Food, Drug, and Cosmetic Act and other requirements listed in the consent decree.

Neovasc Inc . (“Neovasc” or the “Company”) ( Nasdaq , TSX : NVCN) announced today that it has received a “not-approvable” letter from U.S. Food & Drug Administration (FDA) regarding its PMA submission for the Neovasc Reducer™ (Reducer). Fred Colen, Neovasc CEO, said, “While we are disappointed in FDA’s decision, the letter was not unexpected, given the outcome of the Panel meeting.” He continued, “Milli

Australian-based regenerative medicine company, Orthocell Ltd, has achieved US 510k clearance to market and supply its collagen medical device Striate+TM in the US dental bone and tissue regeneration market.